SNIPR Biome
PrivateLast Round
Series B
Aug 7, 2025
Total Funding Raised
$120.68M
Company Overview
SNIPR Biome is a biotechnology company that develops CRISPR-based medicines designed to treat microbial diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SNIPR Biome Comps
Public and private peers based on sector, stage, and business model.
SNIPR Biome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 7, 2025 | ||||
| Debt | Dec 9, 2024 | ||||
| Grant | Apr 22, 2024 | ||||
| Grant | May 27, 2021 | ||||
| Series A | Mar 11, 2019 |
SNIPR Biome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Lundbeckfonden BioCapital | Series B |
| Cystic Fibrosis Foundation | Series B |
| Wellington Partners | Series A, Series B |
| European Investment Bank | Debt |
| North-East Family Office | Series A, Series B |
| SPRIND | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2025
Developing a phage cocktail to treat Pseudomonas infections.
- Aug 7, 2025
$39.2M raised in Series B funding.
SNIPR Biome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SNIPR Biome's valuation, stock price, and market status.
